Operating Lease, Right-of-Use Asset of Regencell Bioscience Holdings Ltd from 30 Jun 2022 to 30 Jun 2025

Taxonomy & unit: us-gaap: USD
Description: Amount of lessee's right to use underlying asset under operating lease.
Summary: Regencell Bioscience Holdings Ltd quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 30 Jun 2022 to 30 Jun 2025.
Regencell Bioscience Holdings Ltd Operating Lease, Right-of-Use Asset for the quarter ending 30 Jun 2025 was $544,385, a 542% increase year-over-year.
Source SEC data: View on sec.gov

Operating Lease, Right-of-Use Asset, Quarterly (USD)

Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Regencell Bioscience Holdings Ltd Quarterly Operating Lease, Right-of-Use Asset (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q2 2025	$544,385	+$459,605	+542%	30 Jun 2025	20-F	31 Oct 2025	2025	FY
Q2 2024	$84,780	-$366,304	-81%	30 Jun 2024	20-F	31 Oct 2025	2025	FY
Q2 2023	$451,084	-$296,342	-40%	30 Jun 2023	20-F	25 Oct 2024	2024	FY
Q2 2022	$747,426			30 Jun 2022	20-F	27 Oct 2023	2023	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.